Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
iNTS-TCV vaccine in European and African adults
NCT05480800Phase 2Completed
- Sponsor
- GSK
- Start
- Sep 2022
- Primary completion
- Sep 2024
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 2
01
Overview
A Phase 2 trial of iNTS-TCV in invasive non-typhoidal Salmonella infection (iNTS), typhoid fever, sponsored by GSK. Started Sep 2022; status: completed.
02
Drugs
iNTS-TCV
03
Conditions
invasive non-typhoidal Salmonella infection (iNTS)typhoid fever
Beyond the preview
Go deeper on NCT05480800.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05480800.